BEIJING – The current speed of new developments in the 2019-nCov outbreak is illustrated by a Jan. 28, 2020, press conference in Munich, where Andreas Zapf, head of the infection task force in the Bavarian ministry for health and food safety, briefed reporters on the first confirmed German case.
Keeping you up to date on recent developments in oncology, including: New algorithm can distinguish between subtypes in low-grade glioma; Different drivers can turn the wheel in glioblastoma’s vicious cycle; Commercial antibodies underwhelm for studies of PP2A; Foundation awards more than $1M for cancer research; Protons better for sparing cognitive function in pediatric patients.
Keeping you up to date on recent developments in cardiology, including: Long QT genes mostly short on evidence; Cerebrospinal fluid is early culprit in stroke edema; Regenerative HBOT protocols appear to improve cardiac function in healthy aging heart population; Blood test IDs risk of disease linked to stroke, dementia.
BioWorld looks at translational medicine, including: Adapting NGS for coronavirus surveillance; Long QT genes mostly short on evidence; Reservoir dogs don’t hunt; Another reason to get a flu shot; Cerebrospinal fluid is early culprit in stroke edema; Different drivers can turn the wheel in glioblastoma’s vicious cycle; From African genomes, big insights with small sample size; Commercial antibodies underwhelm for studies of PP2A; Tau keeps gliomas in check.
BEIJING – The current speed of new developments in the 2019-nCov outbreak is illustrated by a Jan. 28, 2020, press conference in Munich, where Andreas Zapf, head of the infection task force in the Bavarian ministry for health and food safety, briefed reporters on the first confirmed German case.
When developmental neurobiologist Arnold Kriegstein talks about his work, it sounds for all the world like he is talking about the brains of teenagers. They are stressed. Their identity is mixed up. But putting them in a good environment is helpful to their development. Kriegstein, though, was describing brain organoids.
Keeping you up to date on recent developments in oncology, including: SABR showing promise for spinal metastases; Chromosome amplification drives cancer progression via effects on secretion; IMRT shows well in study of upper-tract urothelial carcinoma
When they work, T cells work great. And the folks at Avidea Technologies Inc. want to make them work more often. Combining expertise in immunology and polymer chemistry, the Baltimore-based startup is developing antigen delivery technology to improve T cell-targeted vaccines.
Two independent groups of researchers have achieved HIV latency reversal not just in T cells in the bloodstream, but also in tissues, in animal models of HIV infection. Latently infected cells, which have nonreplicating HIV integrated into their genomes, are a major barrier to curing HIV, and attempts to reactivate latently infected cells, which would sensitize the virus in them to antiretroviral treatment, are one major area of HIV cure research.
